## **Trustees’ Annual Report for the period** 

**From 1st April 2022  -  31st March 2023** 

**Charity name: United Kingdom Society for Extracellular Vesicles** 


## **Charity registration number: 1185098** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The advancement of public educaton and the<br>promoton of those branches of science<br>concerned with extracellular vesicles.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or services<br>identified in the accounts.|Para 1.17 and<br>1.19|To provide a forum for the promoton  of<br>research within the feld of extracellular<br>vesicles, the discussion of the problems of<br>extracellular vesicle research, encourage<br>research bearing on these problems, and<br>promote, arrange, organise and conduct<br>conferences, meetngs, discussions, seminars<br>and the reading of learned papers.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|The trustees have had regard to PB1 The Public<br>Beneft Requirement statement|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

||<br>SORP reference||
|---|---|---|
|Policy on grant making|Para 1.38|The Society is commited to making grants to<br>individuals and other not for proft and<br>charitable insttutons both in the UK and<br>internatonally for the purpose of furthering any<br>of its objects including knowledge exchange,<br>educaton and public engagement.|
|||We are fully commited to public engagement of<br>science, as well as engagement with the<br>scientfc community. The Societyholds|





|Policy on social investment<br>including program related<br>investment|Para 1.38|materials (virtual and physical) donated by our<br>Trustees, Board Members and ordinary<br>Members, which can be disseminated and used<br>for this purpose|
|---|---|---|
|Contribution made by<br>volunteers|Para 1.38|The organisaton is run entrely by volunteers,<br>including those sitng as Trustees, as Board<br>Members and as Ordinary Members. We are<br>extremely grateful for their expertse and the<br>tme given for the purpose of organising events,<br>disseminaton of relevant scientfc and<br>professional informaton, evaluatng grant<br>applicatons, providing mentorship, partcipatng<br>in public engagement and other actvites<br>related to our Purposes.|
|Other|||



## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|The main way in which UKEV fulfils its<br>Purpose is via organisation of an annual<br>conference and satellite events. In<br>December 2022 we returned to a fully in<br>person conference in Edinburgh (after virtual<br>conferences in 2020 and 2021). The event<br>included a session dedicated to early career<br>researcher education, as well as<br>international plenary speakers, oral and<br>poster presentation sessions, and was<br>preceded by a satellite session (Cross<br>Kingdom RNA) which enabled scientists<br>from a different but highly related field to<br>also engage with our particular area of<br>scientific interest and to further allow<br>networking and fostering of new ideas and<br>collaborations.<br>As part of a wider European MOVE<br>Consortium of National Extracellular Vesicle<br>Societies (NEVS) across Europe, UKEV|





were also were able to provide funding for Early Career Researchers to travel to European laboratories to learn and develop new scientific techniques, which is of benefit to their own progression, but also to the laboratories from which they came and to where they travelled, fostering new collaborations and opportunities for knowledge exchange. UKEV Members also acted as Host Laboratories for Early Career Researchers from other NEVS in the consortium. 

## **Additional information (optional)** You may choose to include further statements where relevant about: 

|<br>Achievements against<br>objectives set|<br>Para 1.41|<br>Our objectves are to deliver a natonal<br>conference and provide grants and funding to<br>further extracellular vesicle research and<br>educaton – we achieved these objectves.|
|---|---|---|
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41|Our fundraising actvites were limited to<br>atractng commercial sponsorships for our<br>annual conference, in order to keep registraton<br>fees afordable for delegates, partcularly<br>students, early career researchers, technicians,<br>those with untenured posts.|
|Investment performance<br>against objectives|Para 1.41|No investment portolio|
|Other|||





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|The charity remains in a healthy position to<br>continue planning our core activities for<br>2023, including organisation of our Annual<br>Conference to be held in Cambridge,<br>European conference in collaboration with<br>other National EV Societies; mobility grants<br>for Early Career Researchers; financial<br>assistance with regional or Special Interest<br>group meetings on a case by case basis.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|Reserves are held to ensure that we are<br>able to run our annual conference in the<br>event that we are not able to find enough<br>commercial sponsors to keep ticket costs to<br>a minimum|
|Amount of reserves held|Para 1.22|£42,860 (31.03.23)|
|Reasons for holding zero<br>reserves|Para 1.22|n/a|
|Details of fund materially in<br>deficit|Para 1.24|n/a|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|n/a|



## **Additional information (optional)** 

## You may choose to include further statements where relevant about: 

|<br>The charity’s principal<br>sources of funds (including<br>any fundraising)|<br>Para 1.47|<br>Commercial sponsorships to cover costs for<br>our flagship annual conference with surplus<br>to fund mobility grants for our members|
|---|---|---|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46|No investment policy|
|||Principal risk to the financial wellbeing of the<br>charity is if our sponsors are no longer able|





|A description of the principal<br>risks facing the charity|Para 1.46|to support us. We are very grateful for their<br>ongoing and long term support.|
|---|---|---|
|Other|||





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|Consttutonal Governing Document|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Board members are elected by the<br>membership, after expressions of interest<br>are submitted. Officers are elected by the<br>Board. Trustees are selected by the elected<br>board.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 


**----- Start of picture text -----**<br>
Policies and procedures<br>adopted for the induction and<br>training of trustees Para 1.51<br>The charity’s organisational<br>structure and any wider<br>network with which the  Para 1.51<br>charity works<br>Relationship with any related<br>parties Para 1.51<br>**----- End of picture text -----**<br>




Other 

## **Reference and Administrative details** 

|Charity name|United Kingdom Society for Extracellular Vesicles|
|---|---|
|Other name the charity uses|UKEV|
|Registered charity number|1185098|
|Charity’s principal address|Royal Veterinary College<br>4 Royal College Street<br>London NW1 0TU|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Nam**<br>**e of**<br>**pers**<br>**on**<br>**(or**<br>**body**<br>**)**<br>**entitl**<br>**ed to**<br>**appo**<br>**int**<br>**trust**<br>**ee (if**<br>**any)**|
|---|---|---|---|---|
||Charlotte Lawson|President|||
||Jason Webber|Secretary|||
||LesleySmyth|Treasurer|||
||Ryan Pink|Communications|||
||David Carter||||
||Aled Clayton||||
||Rachel Crossland||||
||Andrew Devitt||||
||Christopher<br>Gardiner||||
||Paul Harrison||||
||Stuart Hunt||||
||Victoria James||||
||Daniel Lambert||||
||Manu Vatish||||
||||||
||||||
||||||
||||||
||||||
||||||



## – Corporate trustees names of the directors at the date the report was approved 

## **Director name** 

**n/a** 



Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|**n/a**|||
||||
||||
||||
||||
||||





## **Funds held as custodian trustees on behalf of others** 

Description of the assets n/a held in this capacity Name and objects of the n/a charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for n/a safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

||**Type of**<br>**adviser**<br>**Name**<br>**Address**|**Type of**<br>**adviser**<br>**Name**<br>**Address**|**Type of**<br>**adviser**<br>**Name**<br>**Address**|
|---|---|---|---|
||**n/a**|||
|||||
|||||
|||||
||**Name of chief executive or names of senior staff members (Optional information)**|||
||n/a|||



## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

**n/a** 

## **Other optional information** 

## **none** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees Signature(s) Full name(s)** Charlotte Lawson **Position (eg** President **Secretary, Chair, etc) Date** 22nd August 2024 



|Control sheet|Control sheet|Control sheet|
|---|---|---|
|Name<br>Charity number:<br>Year End<br>Previous Year End<br>Bank Account No :<br>Nature of Business<br>Director<br>VAT Registered :<br>Type<br>Prepared by<br>Reviewed by||United Kingdom Society for Extracellular Vesicles<br>1185098<br>31-Mar-23<br>31-Mar-22<br>Business Current Account<br>NA<br>Trust<br>VSR<br>RN,AN<br>Supporting the development of extracellular vesicle<br>education & research across the UK|





UNITED KINGDOM SOCIETY FOR EXTRACELLULAR FOR THE YEAR ENDED 31 MARCH 2023 

## NOTES ON ACCOUNTS 

|Sch Ref|S.No.|Group|
|---|---|---|
|K 1<br>L 3|1<br>2|Bank Account<br>Accruals<br>Revenue<br>Conferences & Events<br>Speaker Payments<br>Membership fee paid<br>Debtors<br>Expenses Claim|





VESICLES 

## Queries / Observations 

Bank accounts shows the closing balance of £50,860.11. Agreed with Statement. 

The Closing accruals is the carryforwarded balance of £8,000.00 accrued in previous years as expenses for Crick Institute. There were no payments made during the year to Crick Institute and hence, we have carry forwarded the opening accruals. 

The revenue for the year has increased by £27,471. Last year, the grant and sponsorship income was only £5,268; in the current year, it is £32,738.60. 

Conferences & Events: There is an increase of £24,866 in current year and majorly incurred on the below: 

a. Scottish CafeD- £6,732 b. Satire Hospitality - £13,191 c. Royal College Of P Ukev Meeting -£ 4,255 d. Fatma Isik Move Fellowship336- £2,000 

Breakup of expenses provided in Schedule V3- Conferences & events 

Current Year we have accounted for Speaker payments of £ 3,274 as against NIL in the previous year. 

Payment made to "Dan Lambert Membership Charges" of £687.95 accounted under this head. 

We have noted the below Invoices issued by UKEV during the year, but these are not included as Income and the receipts for the same was also not received during the year. 


We have noted that an expenses claim form given by "Fatma Busra Isik" on 08-02-2023 for the period from 04.10.22 to 14.12.22 for £2,294. We have noted that there is one payment of £2000.00 paid during the year narration with (Fatma Isik Move Fellowship 336).  Please advise, do we need to make any accrual for the balance amount not paid. 



|United Kingdom Society for Extracellular Vesicles<br>Charity number: 1185098<br>Balance sheet for theyear ended 31.03.2023|United Kingdom Society for Extracellular Vesicles<br>Charity number: 1185098<br>Balance sheet for theyear ended 31.03.2023|
|---|---|
|31-Mar-23<br>£<br>Current assets<br>Bank account<br>50,860<br>Current liabilities<br>Accruals<br>8,000<br>42,860<br>Retained funds<br>Income & expenditure account<br>Balance b/fwd<br>41,402<br>Surplus for the year<br>1,458<br>Balance c/fwd<br>42,860<br>-|31-Mar-22<br>£<br>49,402<br>8,000<br>41,402<br>39,274<br>2,127<br>41,402<br>-|





||United Kingdom Society for Extracellular Vesicles<br>Charity number: 1185098<br>Income & expenditure account for theyear ended 31.03.2023|United Kingdom Society for Extracellular Vesicles<br>Charity number: 1185098<br>Income & expenditure account for theyear ended 31.03.2023||
|---|---|---|---|
||Income :<br>Grants & sponsership<br>Membership fees<br>Less: Expenses<br>Conferences & events<br>28,992.33<br>Subscription<br>127.35<br>Membership fees paid<br>687.95<br>Speaker Payments<br>3,273.74<br>Accountancy<br>1,109.88<br>Bank charges<br>261.20|31-Mar-23<br>£<br>32,738.60<br>3,172.27<br>35,910.87<br> <br>4,126.19<br> <br>147.83<br> <br>-<br> <br>-<br> <br>1,109.88<br> 34,452.45<br>87.00<br>1,458.42|31-Mar-22<br>£<br>5,268.00<br>2,330.38|
||||7,598.38<br> <br> <br> <br> <br> <br> 5,470.90|
|||||
||||2,127.48|





## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## EXTENDED TRIAL BALANCE 

|Software NC|Particulars|Opening Balance as per FS|Opening Balance as per FS|
|---|---|---|---|
|||Dr|Cr|
||Bank Current Account<br>Accruals<br>Retained earnings<br>Grants & sponsership<br>Membership fees<br>Conferences & events<br>Subscription<br>Membership fees paid<br>Speaker Payments<br>Accountancy<br>Bank charges|49,401.69|8,000.00<br>41,401.69|
||Total|49,401.69|49,401.69|



- 



|Bank Account|Bank Account|Journals|Journals|Journals|Journals|Closing TB|Closing TB|
|---|---|---|---|---|---|---|---|
|Dr|Cr||Dr|Cr||Dr|Cr|
|35,910.87<br>28,992.33<br>127.35<br>687.95<br>3,273.74<br>1,109.88<br>261.20|34,452.45<br>32,738.60<br>3,172.27|||||50,860.11<br>28,992.33<br>127.35<br>687.95<br>3,273.74<br>1,109.88<br>261.20|8,000.00<br>41,401.69<br>32,738.60<br>3,172.27|
|70,363.32|70,363.32||0.00|0.00||85,312.56|85,312.56|
|-<br>-<br>-||||||||





|Descriptions|Balance|Sch Ref|Balance as per<br>Control<br>account|
|---|---|---|---|
|Bank Current Account<br>Accruals<br>Retained earnings<br>Grants & sponsership<br>Membership fees<br>Conferences & events<br>Subscription<br>Membership fees paid<br>Speaker Payments<br>Accountancy<br>Bank charges|50,860.11<br>(8,000.00)<br>(41,401.69)<br>(32,738.60)<br>(3,172.27)<br>28,992.33<br>127.35<br>687.95<br>3,273.74<br>1,109.88<br>261.20|K 1<br>L 3<br>B/fwd|50,860.11<br>(8,000.00)<br>(41,401.69)|
||0.00||1,458.42|



1,458.42 - 



Check
Comments
0.00
0.00
0.00
0.00

## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## DEBTORS LEAD SCHEDULE 

|Sch Ref|Particulars|31-Mar-23|31-Mar-22|
|---|---|---|---|
|K 1|Bank Control Account|50,860.11|49,401.69|
||Total|50,860.11|49,401.69|





## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## DEBTORS LIST 

|Date|Inv.no|Customer|
|---|---|---|
|11/17/2022<br>11/8/2002<br>11/17/2022<br>11/17/2022<br>11/17/2022<br>11/9/2022<br>11/9/2022<br>11/9/2022<br>11/9/2022<br>11/8/2002<br>6/10/2022<br>6/23/2022<br>11/10/2022<br>6/10/2022<br>11/9/2022<br>11/14/2022<br>11/21/2022<br>6/9/2022 <br>11/1/2022<br>11/1/2022|UKEV2022/3<br>UKEV2022<br>UKEV2022/2<br>UKEV2022/4<br>UKEV2022/1<br>UKEV2022<br>UKEV2022<br>UKEV2022<br>UKEV2022<br>UKEV2022<br>UKEV2021-00x<br>UKEV2022-002<br>UKEV2022-003<br>UKEV2022-002<br>UKEV2022-002<br>UKEV2022-002<br>UKEV2022-002<br>UKEV2021-001<br>UKEV2022-002<br>UKEV2022-002|Institute of Life Science 1<br>Evox Therapeutics Limited<br>Institute of Life Science 1<br>Institute of Life Science 1<br>Institute of Life Science 1<br>Ms Laura Krassini<br>Ms Mikayla Shelton<br>Dr Pamela Holland<br>Dr Pietro Spanu<br>Dr Ronelle Roth<br>NanoView Biosciences - Daniel Croucher<br>Analytik Ltd - Karina Davies<br>Cell Guidance Systems - Michael Jones<br>Beckman Coulter UK Ltd - Martijn Meeuwissen<br>Luminex B.V. -Marcha vander Steen<br>Abbelight - Sybille Capelle<br>Meritics Ltd<br>Oxford Nanoimaging - Sadonna Cody<br>Fox Biosystems - Susanne Lovell<br>Ellarcus Biosciences -Tom Maslanik|
||||






AqldltlM•l Infornb•
VAT%
VAT
UKEV
2022
ECR
£150.111
£150.0
Unlted Klngdom Soclety for Extracellular Veslcle
INVOICE
Invc4ce D*•".
17-11_22
J•aWAJKEV
DUE DATE: One IAonth
TO: Dr Jason Webber
Ing*uts ol Ll• 1
Pwk Canws

AddhlM•l Infrnt
Un*
prf
VAT%
VAT
UKEV
2022
£140.fJ)
t140.(
Unlted Klngdom Soclot)
IN
TO: Dr Ronelle Roth
VKEV
2022

ECR
£120.1

|Particulars|Amount||Received|
|---|---|---|---|
|ECR Non Member<br>Industry  Member & Academic Member<br>ECR Non Member<br>Student Non Member<br>Academic Member<br>Student Non Member<br>Student Non Member<br>Academic Non Member<br>Academic Non Member<br>ECR Member<br>Ukev-2022 Gold Sponsorship Package<br>Ukev-2022 Gold Sponsorship Package<br>Ukev-2022 Silver Sponsorship Package<br>Ukev-2022 Gold Sponsorship Package<br>Ukev-2022 Gold Sponsorship Package<br>Ukev-2022 Silver Sponsorship Package<br>Ukev-2022 Silver Sponsorship Package<br>Ukev-2022 Platinum Sponsorship Package<br>Ukev-2022 Silver Sponsorship Package<br>Ukev-2022 Silver Sponsorship Package|||780.00<br>115.00<br>145.00<br>1,500.00<br>1,500.00<br>1,000.00<br>1,500.00<br>1,500.00<br>989.00<br>1,000.00<br>2,000.00<br>998.46<br>1,000.00|
||150.00|||
||780.00|||
||150.00<br>110.00<br>140.00|||
||115.00|||
||65.00<br>145.00|||
||145.00|||
||120.00|||
||1,500.00<br>1,500.00<br>1,000.00<br>1,500.00<br>1,500.00<br>1,000.00<br>1,000.00<br>2,000.00<br>1,000.00<br>1,000.00|||
||14,920.00||14,027.46|







SI￿901(￿ Pa￿ Camws
Swansea. SA2 8PP
Unlted Kknojom
Addltk>MI Inf0m￿tIon
Unlt Prfc•
VAT%
UKEV
2022
ECR Non
Mernb8r
£I￿.{KI
Unlted Klngdom Soclety for Extracellul2
INVOICE
V•5KI•s
InN¥)k• Nunber.
DUE DATE:
TO . fvts P4ikayla Shelton
Addltlonal Informatk>n

VAT%
ra
UKEV
conf￿
2022
Studwt N
11
£65.Tr)
Totsl
T¢*al VAT
TOTAL AMOUN.
I for Extracellular Veslclas
VOICE
Invc4cfj 0*0". C&11.22
knvcKe Nufflbw.
DUE DATE:
One Month
VAT%
VAT
Total

£T20.C
£120.(¥1
Totsi VAT
£ooK)
t 120Ag
Jqwnt41•thi1s hyhlyhted below"

## Schedule J 1 

Date 2-Dec-22 16-Nov-22 11-Nov-22 5-Dec-22 18-Jul-22 14-Nov-22 8-Jul-22 12-Dec-22 30-Nov-22 2-Nov-22 1-Jul-22 7-Nov-22 29-Nov-22 





SThge1￿ Pa￿ Camws
Swansea, S42 8PP
Addltlonal Inforniatlon
VAT
Unlt
Unlt Prfc•
VATI
UKEV
Sknthit Non
£150.C4)
£110.￿)
Ir Veslcles
Unlted Klngdom Soclety for Extracellular V
INVOICE
11-22
Inv(￿¢ Numbw.
UKEV2022
Clignt Ralww￿'.
MSIUKEV
Pwchase Ctder..
DUE DATE:
Oni
One Month
TO: Dr Pamela Holland

VAT 74
VAT
AT
TfA*l
2022
£145.(Xl
£65.(K)
1111
Totsi
Toi•l VAT
£0.
t 6S.00

>llular Veslcles
17.11-22
>8r.
ler.
One Month

VAT
T(thl
£110.ty)
'eslcles
> Month

£145.IXI
£145.Crfl
ÉOLYJ
£ 14&00

## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## BANK & CASH  SUMMARY 

|Sch Ref|Particulars|31-Mar-23|31-Mar-22|
|---|---|---|---|
|||£|£|
|K 1|Bank Control Account|50,860.11|49,401.69|
||Total|50,860.11|49,401.69|





## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## BANK CONTROL ACCOUNT 

## Schedule K 1 

|Sch Ref|Particulars|Dr|Cr|
|---|---|---|---|
|||£|£|
|Opg TB<br>K 1(a)<br>K 1(b)<br>Clg TB|Balance b/fwd<br>Receipts<br>Payments<br>Balance c/fwd|49,401.69<br>35,910.87|34,452.45<br>50,860.11|
||Total|85,312.56|85,312.56|





Closlng Bank Statement
Date
Type
16-Mar-23 CR
20-Mar-23 BP
23-Mar-23 CR
Description
Stripe Payments UK STRIPE
Fatrna Isik MOVE fellowship336
Stripe Payments UK STRIPE
TAXASSIST ACCOUNTS
Paid Out Paid In
Balance
42.82 53626.41
51626.41
14.14 51640.55
28-Mar-23 DD
92.49
51548.06
31-Mar-23 BP
Dan Lambert Membershlp charges
TOTAL CHARGES TO 14MAR2023
687.95
50860.11
05-Apr-23 DR
13-Apr-23 CR
50855.11
Stripe Payments UK STRIPE
14.14 50869.25

50,860.11

## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## RECEIPTS 

|Date|Particulars|Amount|
|---|---|---|
|4-Apr-22<br>5-Apr-22<br>20-Apr-22<br>29-Apr-22<br>17-May-22<br>27-May-22<br>9-Jun-22<br>10-Jun-22<br>17-Jun-22<br>22-Jun-22<br>23-Jun-22<br>24-Jun-22<br>30-Jun-22<br>1-Jul-22<br>4-Jul-22<br>7-Jul-22<br>8-Jul-22<br>12-Jul-22<br>18-Jul-22<br>20-Jul-22<br>27-Jul-22<br>11-Aug-22<br>24-Aug-22<br>14-Sep-22<br>21-Sep-22<br>23-Sep-22<br>28-Sep-22<br>29-Sep-22<br>30-Sep-22<br>3-Oct-22<br>4-Oct-22<br>5-Oct-22<br>6-Oct-22<br>10-Oct-22<br>11-Oct-22<br>13-Oct-22<br>18-Oct-22<br>19-Oct-22<br>20-Oct-22|Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Nanofcm Co., Ltd Danfcmukev001<br>Nanofcm Co., Ltd Ukev2022001<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Oxford Nanoimaging<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Beckman Coulter Un<br>Stripe Payments Uk Stripe<br>Analytik Ltd Ukev2022-002<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe|42.82<br>14.14<br>42.82<br>56.96<br>14.14<br>2,000.00<br>2,000.00<br>28.48<br>14.14<br>42.14<br>14.14<br>14.14<br>28.48<br>2,000.00<br>42.82<br>42.82<br>1,500.00<br>14.14<br>1,500.00<br>14.14<br>42.82<br>28.03<br>42.82<br>42.82<br>42.82<br>28.28<br>113.32<br>13.97<br>14.14<br>28.48<br>28.28<br>14.14<br>28.28<br>42.82<br>28.48<br>28.28<br>28.28<br>70.87<br>28.28|





|21-Oct-22<br>24-Oct-22<br>25-Oct-22<br>26-Oct-22<br>31-Oct-22<br>3-Nov-22<br>7-Nov-22<br>7-Nov-22<br>8-Nov-22<br>9-Nov-22<br>10-Nov-22<br>11-Nov-22<br>11-Nov-22<br>14-Nov-22<br>14-Nov-22<br>15-Nov-22<br>16-Nov-22<br>16-Nov-22<br>17-Nov-22<br>23-Nov-22<br>28-Nov-22<br>29-Nov-22<br>30-Nov-22<br>1-Dec-22<br>2-Dec-22<br>2-Dec-22<br>5-Dec-22<br>5-Dec-22<br>6-Dec-22<br>8-Dec-22<br>8-Dec-22<br>12-Dec-22<br>12-Dec-22<br>13-Dec-22<br>16-Dec-22<br>5-Jan-23<br>10-Jan-23<br>13-Jan-23<br>23-Jan-23<br>6-Feb-23<br>27-Feb-23<br>3-Mar-23<br>9-Mar-23<br>16-Mar-23<br>23-Mar-23|Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Advice Confirms Rbq07112Opsgyutd Fox Biosystems 0000001<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Spanu Pietro Ukev2022<br>Stripe Payments Uk Stripe<br>Cell Guidanc Cellgs<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Advice Confirms Rbc16112E9Tackw1 1/Laura Krassini<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Meritics Limited Ukev2022-002<br>Advice Confirms Rbc29112Khuhxfr4 Cellarcus Bioscien<br>Advice Confirms Rbc30112Khukjz9D 1/Abbelight<br>Stripe Payments Uk Stripe<br>Evox Therape Ltd F<br>Stripe Payments Uk Stripe<br>Advice Confirms Rbc05122Htv1998G Unchained Labs<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Diasorin Limited<br>Stripe Payments Uk Stripe<br>Eventbrite Operati<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe|56.53<br>228.24<br>71.30<br>14.14<br>14.14<br>99.78<br>998.46<br>14.14<br>199.76<br>42.42<br>170.88<br>145.00<br>85.24<br>1,000.00<br>113.72<br>42.82<br>115.00<br>14.14<br>42.82<br>14.14<br>1,000.00<br>1,000.00<br>989.00<br>14.14<br>780.00<br>14.14<br>1,500.00<br>42.82<br>142.14<br>1,500.00<br>157.34<br>14,711.14<br>13.97<br>42.82<br>28.48<br>14.14<br>14.14<br>14.14<br>57.16<br>28.48<br>115.02<br>56.50<br>14.14<br>42.82<br>14.14|
|---|---|---|





35,910.87 

|Nanofcm Co., Ltd Danfcmukev001<br>Nanofcm Co., Ltd Ukev2022001<br>Oxford Nanoimaging<br>Beckman Coulter Un<br>Analytik Ltd Ukev2022-002<br>Advice Confirms Rbq07112Opsgyutd Fox Biosystems 0000001<br>Spanu Pietro Ukev2022<br>Cell Guidanc Cellgs<br>Advice Confirms Rbc16112E9Tackw1 1/Laura Krassini<br>Meritics Limited Ukev2022-002<br>Advice Confirms Rbc29112Khuhxfr4 Cellarcus Bioscien<br>Advice Confirms Rbc30112Khukjz9D 1/Abbelight<br>Evox Therape Ltd F<br>Advice Confirms Rbc05122Htv1998G Unchained Labs<br>Diasorin Limited<br>Eventbrite Operati|2000<br>2000<br>2000<br>1500<br>1500<br>998.46<br>145<br>1000<br>115<br>1000<br>1000<br>989<br>780<br>1500<br>1500<br>14711.14|
|---|---|





Matched with Invoice 

## Schedule K 1 (a) 

|Head|Membershipfees|Grants &<br>sponsership|
|---|---|---|
|Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees|42.82<br>14.14<br>42.82<br>56.96<br>14.14<br>28.48<br>14.14<br>42.14<br>14.14<br>14.14<br>28.48<br>42.82<br>42.82<br>14.14<br>14.14<br>42.82<br>28.03<br>42.82<br>42.82<br>42.82<br>28.28<br>113.32<br>13.97<br>14.14<br>28.48<br>28.28<br>14.14<br>28.28<br>42.82<br>28.48<br>28.28<br>28.28<br>70.87<br>28.28|2,000.00<br>2,000.00|
|||2,000.00|
||||
|||1,500.00|
||||
|||1,500.00|
||||





|Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Grants & sponsership<br>Grants & sponsership<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Grants & sponsership<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees<br>Membership fees|56.53<br>228.24<br>71.30<br>14.14<br>14.14<br>99.78<br>14.14<br>199.76<br>42.42<br>170.88<br>85.24<br>113.72<br>42.82<br>14.14<br>42.82<br>14.14<br>14.14<br>14.14<br>42.82<br>142.14<br>157.34<br>13.97<br>42.82<br>28.48<br>14.14<br>14.14<br>14.14<br>57.16<br>28.48<br>115.02<br>56.50<br>14.14<br>42.82<br>14.14||
|---|---|---|
|||998.46|
||||
|||145.00|
||||
|||1,000.00|
||||
|||115.00|
||||
|||1,000.00<br>1,000.00<br>989.00|
||||
|||780.00|
||||
|||1,500.00|
||||
|||1,500.00|
|||14,711.14|





3,172.27
32,738.60

UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## BANK CONTROL ACCOUNT 

|Date|Particulars|Amount|
|---|---|---|
|5-Apr-22<br>11-Apr-22<br>28-Apr-22<br>6-May-22<br>30-May-22<br>5-Jun-22<br>28-Jun-22<br>6-Jul-22<br>28-Jul-22<br>5-Aug-22<br>30-Aug-22<br>5-Sep-22<br>28-Sep-22<br>6-Oct-22<br>14-Oct-22<br>28-Oct-22<br>5-Nov-22<br>7-Nov-22<br>10-Nov-22<br>24-Nov-22<br>24-Nov-22<br>28-Nov-22<br>28-Nov-22<br>29-Nov-22<br>30-Nov-22<br>5-Dec-22<br>6-Dec-22<br>15-Dec-22<br>15-Dec-22<br>15-Dec-22<br>15-Dec-22<br>27-Dec-22<br>28-Dec-22<br>28-Dec-22<br>5-Jan-23<br>18-Jan-23<br>18-Jan-23<br>19-Jan-23<br>19-Jan-23<br>23-Jan-23|Total Charges To 14Mar2022<br>Ryan Pink Ukev Website<br>Taxassist Accounts<br>Total Charges To 14Apr2022<br>Taxassist Accounts<br>Total Charges To 14May2022<br>Taxassist Accounts<br>Total Charges To 14Jun2022<br>Taxassist Accounts<br>Total Charges To 14Jul2022<br>Taxassist Accounts<br>Total Charges To 14Aug2022<br>Taxassist Accounts<br>Total Charges To 14Sep2022<br>Ibis Styles Lqflcbqk<br>Taxassist Accounts<br>Total Charges To 14Oct2022<br>Notprovided Rbq07112Opsgyutd<br>Paul Sinclair Clawsonukev<br>Lesley A Smyth Ukevprintingpay<br>P. Correia Pinto M Ukevbadgespayment<br>Taxassist Accounts<br>The Scottish Cafe 20113<br>Ftc6680601 01 Rbc29112Khuhxfr4<br>Gbs30112Fvuejf29 Rbc30112Khukjz9D<br>Gbc05122H8V18Uo1 Rbc05122Htv1998G<br>Total Charges To 14Nov2022<br>Cathy Park Poster Runner Up<br>Daan Paget Talk Winner<br>Hannah Jackson Poster Winner<br>Sonia Guarnerio Talk Runner Up<br>Saltire Hospitalit Inv-1414<br>Saltire Hospitalit Inv-1414<br>Taxassist Accounts<br>Total Charges To 14Dec2022<br>Isev Payment Rbd18013E91M7Ce8 Mme Benedetti Rapo<br>Isev Payment Rbd18013E91M7Ce8 Payment Charge<br>Ukev Payment Rbd19013H91Rzydc Bernd Giebel<br>Ukev Payment Rbd19013H91Rzydc Payment Charge<br>Ukev Speaker Pay Rbd23013E9255Zsw Hailing Jin|11.00<br>127.35<br>92.49<br>5.00<br>92.49<br>11.00<br>92.49<br>11.00<br>92.49<br>11.00<br>92.49<br>11.00<br>92.49<br>5.00<br>720.00<br>92.49<br>5.00<br>0.20<br>765.00<br>50.80<br>161.89<br>92.49<br>6,732.25<br>6.00<br>6.00<br>6.00<br>5.00<br>50.00<br>100.00<br>100.00<br>50.00<br>6,595.50<br>6,595.50<br>92.49<br>11.00<br>339.94<br>17.00<br>433.80<br>17.00<br>500.00|





|23-Jan-23<br>24-Jan-23<br>24-Jan-23<br>25-Jan-23<br>25-Jan-23<br>26-Jan-23<br>26-Jan-23<br>27-Jan-23<br>27-Jan-23<br>30-Jan-23<br>5-Feb-23<br>24-Feb-23<br>24-Feb-23<br>24-Feb-23<br>27-Feb-23<br>27-Feb-23<br>28-Feb-23<br>8-Mar-23<br>20-Mar-23<br>28-Mar-23<br>31-Mar-23|Ukev Speaker Pay Rbd23013E9255Zsw Payment Charge<br>Ukev Payment Rbd24013Ea28Gg1T Payment Charge<br>Ukev Payment Rbd24013Ea28Gg1T Van Niel Guillaume<br>Ukev Payment Rbd25013H92Br01T Payment Charge<br>Ukev Payment Rbd25013H92Br01T Van Niel Guillaume<br>Part 2 Ukev Paym Rbd26013El2F1K5C Hailing Jin<br>Part 2 Ukev Paym Rbd26013El2F1K5C Payment Charge<br>Part 3 Ukev Paym Rbd27013Ki2Ic1A9 Hailing Jin<br>Part 3 Ukev Paym Rbd27013Ki2Ic1A9 Payment Charge<br>Taxassist Accounts<br>Total Charges To 14Jan2023<br>Jin Payment 4 Rbd24023Hs52Jebk Hailing Jin<br>Jin Payment 4 Rbd24023Hs52Jebk Payment Charge<br>Royal College Of P Ukev Meeting<br>Jin Payment 5 Rbd27023E95Ce2O0 Hailing Jin<br>Jin Payment 5 Rbd27023E95Ce2O0 Payment Charge<br>Taxassist Accounts<br>Total Charges To 14Feb2023<br>Fatma Isik Move Fellowship336<br>Taxassist Accounts<br>Dan Lambert Membership Charges|17.00<br>17.00<br>500.00<br>17.00<br>298.39<br>500.00<br>17.00<br>500.00<br>17.00<br>92.49<br>11.00<br>500.00<br>17.00<br>4,255.00<br>500.00<br>17.00<br>92.49<br>11.00<br>2,000.00<br>92.49<br>687.95|
|---|---|---|
|||34,452.45|





Sc 

|Head|Conferences &<br>events|Membership<br>|Speakers<br>Payments|Subscription|Accountancy<br>fees|
|---|---|---|---|---|---|
|Bank Charges<br>Subscription<br>Accountancy fees<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Conferences & events<br>Accountancy fees<br>Bank Charges<br>Bank Charges<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Accountancy fees<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Bank Charges<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Conferences & events<br>Accountancy fees<br>Bank Charges<br>Speakers Payments<br>Bank Charges<br>Speakers Payments<br>Bank Charges<br>Speakers Payments|720.00<br>765.00<br>50.80<br>161.89<br>6,732.25<br>6.00<br>6.00<br>6.00<br>50.00<br>100.00<br>100.00<br>50.00<br>6,595.50<br>6,595.50|<br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br> <br>|339.94<br>433.80<br>500.00|127.35<br> <br> <br>|<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49|





|Bank Charges<br>Bank Charges<br>Conferences & events<br>Bank Charges<br>Conferences & events<br>Speakers Payments<br>Bank Charges<br>Speakers Payments<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Speakers Payments<br>Bank Charges<br>Conferences & events<br>Speakers Payments<br>Bank Charges<br>Accountancy fees<br>Bank Charges<br>Conferences & events<br>Accountancy fees<br>Membership|500.00<br>298.39<br>4,255.00<br>2,000.00|<br> <br> <br> <br>687.95|500.00<br>500.00<br>500.00<br>500.00<br>|<br> <br> <br>|92.49<br>92.49<br>92.49|
|---|---|---|---|---|---|
||28,992.33|687.95|3,273.74|127.35|1,109.88|





## chedule K 1 (b) 

Bank Charges 11.00 5.00 11.00 11.00 11.00 11.00 5.00 5.00 0.20 5.00 11.00 17.00 17.00 



17.00 17.00 17.00 17.00 17.00 11.00 17.00 17.00 11.00 261.20 



## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## CREDITORS LEAD SCHEDULE LESS THAN ONE YEAR 

|Sch Ref|Particulars|31-Mar-23|31-Mar-22|
|---|---|---|---|
|L 3|Accruals|8,000.00|8,000.00|
||Total|8,000.00|8,000.00|





UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## LIST OF CREDITORS 

|Date|Inv.no|Supplier|Particulars|Amount|
|---|---|---|---|---|
|11/23/2022<br>9615063 Viking<br>Od Clip Badge<br>12/9/2022<br>1414 Saltire Hospitality<br>Tea/coffee Luch<br>6/24/2021<br>19647 Royal College of Physicians of Edinburgh|||||
|||||17,607.89|





Schedule L 1 (a) 

|Paid|Date|Difference|
|---|---|---|
|161.89<br>11/24/2022<br>0<br>13,191.00<br>0<br>4,255.00<br>24-Feb-23<br>0<br>17,607.89<br>27/11/22 &<br>28/11/22|||





## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## ACCRUALS AND DEFERRED INCOME 

## Schedule L 3 

|Ref|Particulars|31-Mar-23|31-Mar-22|** B/fwd|
|---|---|---|---|---|
|||£|£||
|TB|Opeing Balance|8,000.00|8,000.00||
||Total|8,000.00|8,000.00||



** During the year, there were no payments made to Crick Institute. Hence, carry forward 



The accrual relate5 to Crick Institute.
If any payments has been made to thern this financial year please reduce the accrual by that amount, if not don,
to next year.

t reduce the accruals.

UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## INCOME AND EXPENSES COMPARISON 

P & L BRIDGE 

|Particulars|31-Mar-23|31-Mar-23|31-Mar-22|31-Mar-22|Deviations|Deviations|Analytical Review Notes|Sch Ref||£|
|---|---|---|---|---|---|---|---|---|---|---|
||£|£|£|£|£|%|||||
|Income<br>Grants & sponsership<br>Membership fees<br>Expenses<br>Conferences & events<br>Subscription<br>Membership fees paid<br>Speaker Payment<br>Accountancy<br>Finance Costs<br>Bank charges||32,738.60<br>3,172.27||5,268.00<br>2,330.38|27,470.60<br>841.89<br>(24,866.14)<br>20.48<br>(687.95)<br>(3,273.74)<br>0.00<br>(174.20)|521.46%<br>36.13%<br>(602.64)%<br>13.85%<br>100.00%<br>100.00%<br>0.00%<br>(200.23)%|Breakup provided<br>Breakup provided<br>Breakup provided<br>Breakup provided<br>Breakup provided|V 1<br>V 2<br>V 3<br>V 5<br>V 4||2,127.48<br>28,312.49<br>(28,981.55)|
||28,992.33<br>127.35<br>687.95<br>3,273.74<br>1,109.88<br>261.20|35,910.87<br>34,452.45|4,126.19<br>147.83<br>0.00<br>0.00<br>1,109.88<br><br>87.00|7,598.38<br>5,470.90|||||||
||||||||||||
|NetProfit / (Loss)||1,458.42||2,127.48||||||1,458.42|





Particulars Profit before tax for the year ended 31st March 2022 Increase/ (Decrease) in Turnover at last years gross Margin Increase/ (Decrease) in Admisnistrative costs Profit before tax for the year ended 31st March 2023 



## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## GRANTS & SPONSERSHIP 

## Schedule V 1 

|Date|Particulars|Dr|Cr|
|---|---|---|---|
|27-May-22<br>9-Jun-22<br>1-Jul-22<br>8-Jul-22<br>18-Jul-22<br>7-Nov-22<br>11-Nov-22<br>14-Nov-22<br>16-Nov-22<br>28-Nov-22<br>29-Nov-22<br>30-Nov-22<br>2-Dec-22<br>5-Dec-22<br>8-Dec-22<br>12-Dec-22<br>Clg TB|Nanofcm Co., Ltd Danfcmukev001<br>Nanofcm Co., Ltd Ukev2022001<br>Oxford Nanoimaging<br>Beckman Coulter Un<br>Analytik Ltd Ukev2022-002<br>Advice Confirms Rbq07112Opsgyutd Fox Biosystems 0000001<br>Spanu Pietro Ukev2022<br>Cell Guidanc Cellgs<br>Advice Confirms Rbc16112E9Tackw1 1/Laura Krassini<br>Meritics Limited Ukev2022-002<br>Advice Confirms Rbc29112Khuhxfr4 Cellarcus Bioscien<br>Advice Confirms Rbc30112Khukjz9D 1/Abbelight<br>Evox Therape Ltd F<br>Advice Confirms Rbc05122Htv1998G Unchained Labs<br>Diasorin Limited<br>Eventbrite Operati<br>Closing balance B/fwd|.16374057 /T<br>32,738.60|2,000.00<br>2,000.00<br>2,000.00<br>1,500.00<br>1,500.00<br>m<br>998.46<br>145.00<br>1,000.00<br>115.00<br>1,000.00<br>1,000.00<br>989.00<br>780.00<br>1,500.00<br>1,500.00<br>14,711.14|
||Total|32,738.60|32,738.60|





UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## MEMBERSHIP FEES: 

## Schedule V 2 

|Date|Particulars|Dr|Cr|
|---|---|---|---|
|4-Apr-22<br>5-Apr-22<br>20-Apr-22<br>29-Apr-22<br>17-May-22<br>10-Jun-22<br>17-Jun-22<br>22-Jun-22<br>23-Jun-22<br>24-Jun-22<br>30-Jun-22<br>4-Jul-22<br>7-Jul-22<br>12-Jul-22<br>20-Jul-22<br>27-Jul-22<br>11-Aug-22<br>24-Aug-22<br>14-Sep-22<br>21-Sep-22<br>23-Sep-22<br>28-Sep-22<br>29-Sep-22<br>30-Sep-22<br>3-Oct-22<br>4-Oct-22<br>5-Oct-22<br>6-Oct-22<br>10-Oct-22<br>11-Oct-22<br>13-Oct-22<br>18-Oct-22<br>19-Oct-22<br>20-Oct-22<br>21-Oct-22<br>24-Oct-22<br>25-Oct-22<br>26-Oct-22<br>31-Oct-22|Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe||42.82<br>14.14<br>42.82<br>56.96<br>14.14<br>28.48<br>14.14<br>42.14<br>14.14<br>14.14<br>28.48<br>42.82<br>42.82<br>14.14<br>14.14<br>42.82<br>28.03<br>42.82<br>42.82<br>42.82<br>28.28<br>113.32<br>13.97<br>14.14<br>28.48<br>28.28<br>14.14<br>28.28<br>42.82<br>28.48<br>28.28<br>28.28<br>70.87<br>28.28<br>56.53<br>228.24<br>71.30<br>14.14<br>14.14|





|3-Nov-22<br>7-Nov-22<br>8-Nov-22<br>9-Nov-22<br>10-Nov-22<br>11-Nov-22<br>14-Nov-22<br>15-Nov-22<br>16-Nov-22<br>17-Nov-22<br>23-Nov-22<br>1-Dec-22<br>2-Dec-22<br>5-Dec-22<br>6-Dec-22<br>8-Dec-22<br>12-Dec-22<br>13-Dec-22<br>16-Dec-22<br>5-Jan-23<br>10-Jan-23<br>13-Jan-23<br>23-Jan-23<br>6-Feb-23<br>27-Feb-23<br>3-Mar-23<br>9-Mar-23<br>16-Mar-23<br>23-Mar-23<br>Clg TB|Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Stripe Payments Uk Stripe<br>Closing balance B/fwd|3,172.27|99.78<br>14.14<br>199.76<br>42.42<br>170.88<br>85.24<br>113.72<br>42.82<br>14.14<br>42.82<br>14.14<br>14.14<br>14.14<br>42.82<br>142.14<br>157.34<br>13.97<br>42.82<br>28.48<br>14.14<br>14.14<br>14.14<br>57.16<br>28.48<br>115.02<br>56.50<br>14.14<br>42.82<br>14.14|
|---|---|---|---|
||Total|3,172.27|3,172.27|





## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## CONFERENCES & EVENTS 

|Date|Particulars|Dr|
|---|---|---|
|14-Oct-22<br>10-Nov-22<br>24-Nov-22<br>24-Nov-22<br>28-Nov-22<br>29-Nov-22<br>30-Nov-22<br>5-Dec-22<br>15-Dec-22<br>15-Dec-22<br>15-Dec-22<br>15-Dec-22<br>27-Dec-22<br>28-Dec-22<br>24-Jan-23<br>25-Jan-23<br>24-Feb-23<br>20-Mar-23<br>Clg TB|Ibis Styles Lqflcbqk<br>Paul Sinclair Clawsonukev<br>Lesley A Smyth Ukevprintingpay<br>P. Correia Pinto M Ukevbadgespayment|720.00<br>765.00<br>50.80<br>161.89|
||The Scottish Cafe 20113|6,732.25|
||Ftc6680601 01 Rbc29112Khuhxfr4<br>Gbs30112Fvuejf29 Rbc30112Khukjz9D<br>Gbc05122H8V18Uo1 Rbc05122Htv1998G<br>Cathy Park Poster Runner Up<br>Daan Paget Talk Winner<br>Hannah Jackson Poster Winner<br>Sonia Guarnerio Talk Runner Up|6.00<br>6.00<br>6.00<br>50.00<br>100.00<br>100.00<br>50.00|
||Saltire Hospitalit Inv-1414<br>Saltire Hospitalit Inv-1414|6,595.50<br>6,595.50|
||Ukev Payment Rbd24013Ea28Gg1T Van Niel Guillaume<br>Ukev Payment Rbd25013H92Br01T Van Niel Guillaume|500.00<br>298.39|
||Royal College Of P Ukev Meeting<br>Fatma Isik Move Fellowship336|4,255.00<br>2,000.00|
||Closing balance B/fwd||
||Total|28,992.33|





Schedule V3
Cr
28,992.33
28,992.33

UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## ACCOUNTANCY 

|Date|Particulars|Dr|
|---|---|---|
|28-Apr-22<br>30-May-22<br>28-Jun-22<br>28-Jul-22<br>30-Aug-22<br>28-Sep-22<br>28-Oct-22<br>28-Nov-22<br>28-Dec-22<br>30-Jan-23<br>28-Feb-23<br>28-Mar-23<br>Clg TB|Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Taxassist Accounts<br>Closing balance B/fwd|92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49<br>92.49|
||Total|1,109.88|





Schedule V4
Cr
1,109.88
1,109.88

## UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES FOR THE YEAR ENDED 31 MARCH 2023 

## SPEAKER PAYMENTS 

|Date|Particulars|Dr|
|---|---|---|
|18-Jan-23<br>19-Jan-23<br>23-Jan-23<br>26-Jan-23<br>27-Jan-23<br>24-Feb-23<br>27-Feb-23<br>Clg TB|Isev Payment Rbd18013E91M7Ce8 Mme Benedetti Rapo<br>Ukev Payment Rbd19013H91Rzydc Bernd Giebel<br>Ukev Speaker Pay Rbd23013E9255Zsw Hailing Jin<br>Part 2 Ukev Paym Rbd26013El2F1K5C Hailing Jin<br>Part 3 Ukev Paym Rbd27013Ki2Ic1A9 Hailing Jin<br>Jin Payment 4 Rbd24023Hs52Jebk Hailing Jin<br>Jin Payment 5 Rbd27023E95Ce2O0 Hailing Jin<br>Closing balance B/fwd|339.94<br>433.80<br>500.00<br>500.00<br>500.00<br>500.00<br>500.00|
||Total|3,273.74|





Schedule V5
Cr
3,273.74
3,273.74

26th August 2024
To whom it may concern
Charity Name: UNITED KINGDOM SOCIEfY FOR ExfRACELLULAR VESIC4ES
Charity Number: 1185098
We have carried out an independent reviewof the record keeping.and financi81
statements of the above charityfortheyearended 2023.
In ouropinion the accounts and financialstatements accurately representthe material
fin8ncial position of the charity.
We carried out this review as accountants, not as registered Auditors.
Should there be any query with the accounts, please contact our offices directly.
Yours taithfully.
Charleswalker
SENIOR PARTNER.
T￿ASSist Accountants Franchises are ow[￿d and operated ufider licen￿.
Bedford
SL Neots
5a Market Hall
0 5yiteGIc
Bedford
Oakpark kniness Centre
MK40 INS
St Neots PE19 6WA
01234 331777
01480 592 (n2
taxa￿stb$h
taXaSSiSL(x).uk
Chades Walker A%wates IHurtsl LTD
HuntinKdon
129 High Street
Huntingd
PE29 3Nf
01480 592 rM)I
taxassistbsh@taxasstsr.co.uk
Charles Walker Awtlates (Hunts) LTO
tèX85515tbsh@tsxa5515t.co.uk
Charfes WalkerA5SOCiates (Beds) ITD